Search Results - "Mirshahidi, H. R."

SWOG S0800 (NCI CDR0000636131): addition of bevacizumab to neoadjuvant nab-paclitaxel with dose-dense doxorubicin and cyclophosphamide improves pathologic complete response (pCR) rates in inflammatory or locally advanced breast cancer by Nahleh, Z. A., Barlow, W. E., Hayes, D. F., Schott, A. F., Gralow, J. R., Sikov, W. M., Perez, E. A., Chennuru, S., Mirshahidi, H. R., Corso, S. W., Lew, D. L., Pusztai, L., Livingston, R. B., Hortobagyi, G. N.

“…SWOG S0800, a randomized open-label Phase II clinical trial, compared the combination of weekly nab-paclitaxel and bevacizumab followed by dose-dense…”
Get full text

Managing early breast cancer: Prognostic features guide choice of therapy by Mirshahidi, Hamid R., Abraham, Jame

“…In the United States, more than 90% of breast cancer diagnoses occur in an early stage of the disease. That so much detection happens early bodes well for the…”
Get full text

Suicide in patients with cancer in California: 2000-2005 by Mirshahidi, H. R., Nasseri, K., Mills, P. K.

“…Abstract only…”
Get full text

SWOG S0800 by Pusztai, L, Hayes, D. F, Hortobagyi, G. N, Perez, E. A, Chennuru, S, Corso, S. W, Livingston, R. B, Gralow, J. R, Mirshahidi, H. R, Schott, A. F, Nahleh, Z. A, Lew, D. L, Sikov, W. M, Barlow, W. E

“…SWOG S0800, a randomized open-label Phase II clinical trial, compared the combination of weekly nab-paclitaxel and bevacizumab followed by dose-dense…”
Get full text

SWOG S0800 rates in inflammatory or locally advanced breast cancer by Nahleh, Z. A, Barlow, W. E, Hayes, D. F, Schott, A. F, Gralow, J. R, Sikov, W. M, Perez, E. A, Chennuru, S, Mirshahidi, H. R, Corso, S. W, Lew, D. L, Pusztai, L, Livingston, R. B, Hortobagyi, G. N

“…SWOG S0800, a randomized open-label Phase II clinical trial, compared the combination of weekly nab-paclitaxel and bevacizumab followed by dose-dense…”
Get full text

Accrual of underrepresented minority women to breast cancer clinical trials in the Inland Empire, California by Yuan, Y., Uppala, P., Lum, S. S., Garberoglio, C., Mirshahidi, H. R., Cassady, R., Morgan, J., Chen, C.

“…Abstract only…”
Get full text

Abstract P6-10-04: “Disparities in breast cancer: A multi-institutional comparative analysis focusing on American Hispanics” by Otoukesh, S, Nahleh, Z, Mirshahidi, HR, Nguyen, AL, Botrus, G, Badri, N, Diab, N, Alvarado, A, Sanchez, LA, Dwivedi, A

“…Abstract Background: Breast cancer (BC) is the leading cause of cancer death in Hispanic/Latina women nationwide. Hispanic women are more likely to be…”
Get full text

CHK-2 expression in lung cancer and tumor sensitivity to DNA damage-inducing therapy by Mirshahidi, H. R., Rogers, J., Tallaksen, R., Szwerc, M., Zhang, P.

“…Abstract only…”
Get full text